Raghu Lakshminarayan

A member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team, Dr. Gandhi specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases.

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude. He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center.

Dr. Gandhi also dedicated an entire year to biomedical research at Memorial Sloan-Kettering Cancer Center and also served as a research fellow at the National Institutes of Health (NIH). Prior to joining Miami Cardiac & Vascular Institute, he was an international visiting scholar at Asan Medical Center/University of Ulsan Medical School in Seoul, South Korea. He has published numerous scientific papers, authored several textbook chapters and presented his research at national and international meetings.

He is also a fellow of the Society for Vascular Medicine and a fellow of the Society of Interventional Radiology. He is the co-author of the textbook Interventional Oncology. Dr. Gandhi is also a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Hermiller serves as Director of the Interventional Cardiology Fellowship, and the Structural Heart Programs at St Vincent Ascension Heart Center in Indianapolis, IN. He is an assistant clinical professor at Duke University. He was recognized as a Master Interventional Cardiologist by the Society of Cardiovascular Angiography and Interventions (SCAI). Dr. Hermiller has expertise in structural heart disease and has been a leading enroller, primary investigator, and steering committee member in many transcatheter therapy studies, including many pivotal trials of coronary and structural heart disease. He has authored or co-authored over 250 published manuscripts. He is past president (2024-2025) of the Society of Cardiac Angiography and Intervention, and his major initiative during his tenure as president was to support advanced radiation protection for operators and staff in the cardiac catheterization laboratory.

Raghu Lakshminarayan has been a Consultant Vascular Radiologist at the Hull University Teaching Hospitals NHS Trust since 2007 & a Senior Lecturer at Hull York Medical School, having moved to this post from a consultant position at the Royal Brisbane Hospital & Senior Lecturer, University of Queensland, Australia.
He has served as Head of Training for the East Yorkshire Training Scheme, deputy Training Programme Director for IR in Yorkshire and as an expert adviser to NICE and the British Standards Institute. He has a strong commitment to education and training and is a current member of Cardiovascular & Interventional Radiology of Europe (CIRSE) education committee and a member of the patient information task force. He is also a member of the Royal College of Radiologists INR credential board and the GMC credentials Task and Finish group.
His research interests include aortic, peripheral vascular, stroke and embolization techniques. He has published extensively and has been an invited speaker at national and international congresses. He has keen interest in AI in the vascular space and is an academic visitor to the department of Computer Science, University of Durham.
He is the Vice President of the British Society of Interventional Radiology (BSIR). He has served the BSIR in many roles including Secretary (2021-23) and organising and delivering the annual scientific conference as the Scientific committee chair in 2018.

Dr. Patrick Muck attended the University of Notre Dame and completed medical school at the University of Kentucky. He completed his vascular fellowship at Good Samaritan Hospital in Cincinnati, Ohio. He currently is the Program Director of the independent and integrated vascular residencies at Good Samaritan Hospital in Cincinnati, Ohio. Dr. Muck is also the Chief of the Section of Vascular Surgery at Good Samaritan Hospital. He is the Site Director for multiple FDA trials at GSH. Dr. Muck has been a speaker and/or moderator at many national and international meetings. He has written and published articles in peer reviewed journals and currently is a reviewer for the Journal of Vascular Surgery. He has authored several book chapters as well. He serves as the Past President for the Midwestern Vascular Surgery Society. He is the Treasurer of the American Venous Forum.

Christopher Steelman is an Assistant Professor and Founding Director of the Cardiac Specialist Program at Weber State University’s School of Radiologic Sciences. His work focuses on artificial intelligence, robotics, and occupational safety in the cath lab. He co-chairs the American College of Cardiology’s Allied Health Professionals Workgroup and serves on the Board of Advisors for Cardiovascular Credentialing International, advancing national standards, credential alignment, and workforce development. He has held multiple roles with the American Society of Radiologic Technologists, including three terms as Chair of the Cardiac Interventional and Vascular Interventional Chapter. An Associate of the American College of Cardiology and a Fellow of the Alliance of Cardiovascular Professionals, Steelman has authored SCAI-endorsed educational guidelines for invasive cardiovascular technology personnel and several textbook chapters on angiography, vascular imaging equipment, and emerging technologies. A frequent international speaker, he has delivered invited lectures in more than 20 countries across Asia, Africa, Europe, and North America. He serves as an editorial advisor for professional journals and mentors early-career technologists and clinicians.

President, ORSIF
Founder & CMO, Rampart IC

Robert Foster MD is an Interventional cardiologist specializing in peripheral endovascular procedures at The Vein Company in Kingsport TN. He practiced as an IC with Birmingham Heart Clinic, in Birmingham Alabama, for 26 years with special interest in peripheral arterial and venous disease before becoming the Chief Medical Officer for Rampart IC. and the President of ORSIF

Dr. Foster is a graduate of Baylor University and received his medical degree from UAB. After residency at UT Southwestern, he returned to UAB for cardiology fellowship. He then went on staff at UAB as the Clinical Director of Cardiac MRI before joining the Birmingham Heart Clinic.

Dr. Foster’s passion now is creating the safest interventional lab environments to protect physicians and staff from the harmful effects of radiation while reducing orthopedic strain and injury.

Dr Bella Hausen obtained her medical degree from the universities of Manchester and Edinburgh where she was initially a plastic surgical trainee with an interest in micro vascular repair. She completed advance microsurgical training at Zurich, and Rhainoplasty Msc at Barcelona. She went on to complete her Radiology and Interventional Radiology specialist registration with the royal college of Radiology London U.K. She completed her advance Endovascular fellowship with Professor Andrew Holden at Auckland University hospital, NewZealand.

Dr Hausen preformed the first lithotripsy in peripheral endovascular CLI disease, along with the first Sirolimus DCB use in both CLI and AVF, in Europe.

Dr Huasen is the head of endovascular research and innovation in Lancashire U.K. Her current interest are training and education of future doctors, radiation protection for patients and staff, CLI management, AVF salvage, pain management and women’s health. She currently works at Lancashire University health trusts U.K.